ALS Limited (ASX:ALQ) has delivered a landmark FY26 with underlying net profit after tax surging 25.8% to $381.2 million, beating 2027 targets a year early and raising its dividend by 10%. The company continues to invest heavily in automation, digital initiatives, and laboratory expansions while advancing its climate strategy amid a post-year-end cyber incident.
- Underlying revenue rises 10.7% to $3.32 billion
- Underlying NPAT grows 25.8% to $381.2 million
- Final dividend up 10.1% to 23.1 cents per share
- Significant investments in automation and hub labs
- Cybersecurity incident causes operational disruption
Record Financial Performance and Dividend Increase
ALS Limited (ASX:ALQ) has reported a standout FY26, delivering underlying net profit after tax (NPAT) of AUD 381.2 million, a 25.8% increase on the prior year and surpassing the company’s FY27 targets a full year ahead of schedule. Underlying revenue grew 10.7% to AUD 3.32 billion, driven primarily by strong demand in its Commodities division, particularly the Minerals business, which saw organic revenue growth of 20.2% and margin expansion to 33.0%.
The Board declared a final dividend of 23.1 cents per share, partially franked at 30%, lifting the full-year dividend to 42.5 cents, up 10.1% on FY25. This payout represents 57% of underlying NPAT, reflecting confidence in the company’s cash flow and balance sheet strength.
Commodities and Life Sciences Drive Growth Amid Mixed Regional Conditions
The Commodities segment, accounting for 39% of revenue, delivered an 18.8% increase in sales to $1.29 billion and underlying EBIT growth of 25.9% to $381.5 million. Minerals testing benefited from robust exploration activity supported by high commodity prices and the accelerating energy transition, while Industrial Materials also posted solid organic growth.
Life Sciences, representing 61% of revenue, grew underlying sales by 6.0% to $2.03 billion with EBIT up 10.2% to $296.5 million. The Food testing business led organic growth at 7.2%, while Pharmaceuticals completed the Nuvisan transformation program, delivering meaningful margin expansion. Environmental testing showed mid-single-digit growth in APAC and EMEA, offset by softer conditions and integration challenges in the Americas.
Strategic Investments in Automation and Laboratory Capacity
ALS continued to invest heavily in its global footprint and technological capabilities, with total capital expenditure rising 59.4% to $263 million. Approximately $93.7 million was invested in four major hub laboratory projects in key locations including Lima, Sydney, Bangkok, and Prague. These hubs are designed to increase capacity and efficiency through smart automation and modern facility design, with Sydney and Lima facilities expected to commission in calendar 2026.
Investment in automation, robotics, and AI-enabled solutions is a key pillar of ALS’ strategy to improve productivity and service delivery, supporting ongoing margin improvement and operational agility. The company’s hub-and-spoke operating model remains a competitive differentiator, enabling scalability and consistent quality across its global network.
Balance Sheet Strength and Capital Management
The company’s balance sheet remains robust, with net debt reduced by $354.6 million to $1.07 billion and gearing lowered to 38.5% (from 52.4%). Leverage stands at a healthy 1.5 times underlying EBITDA, well below the target range, supported by a $367 million equity raise in June 2025 and strong free cash flow generation. ALS maintains over $580 million in unused debt facilities, providing financial flexibility for future growth.
Sustainability and Climate Strategy Progress
ALS advanced its sustainability agenda in FY26, embedding climate-related risks and opportunities into its strategic planning and risk management frameworks. The company reported Scope 1 and 2 greenhouse gas emissions of 56,112 tonnes CO2e (market-based), and is retiring its current 2030 emissions reduction target to develop a revised, science-aligned climate target and transition plan in FY27. ALS continues to focus on operational decarbonisation levers such as energy efficiency, electrification, and renewable energy investment.
Climate scenario analysis conducted by ALS indicates no material financial impact from climate-related risks over short to long-term horizons, reflecting ALS’ diversified global footprint and operational flexibility. The company also highlighted opportunities arising from the energy transition and increasing environmental regulation, which are expected to drive demand for its testing services.
Leadership Changes and Cybersecurity Incident
ALS saw board renewal with the retirement of Tonianne Dwyer and appointment of Christy Boyce as a non-executive director in FY26. Executive leadership also evolved with the planned replacement of the Executive General Manager Minerals following Bruce McDonald’s retirement, and the appointment of Andrea Vallejo as Executive General Manager Environmental in April 2026.
Post-year-end, ALS identified a malicious cyber attack causing temporary disruption to some IT systems and operations. The company has undertaken containment, remediation, and investigation efforts and does not currently anticipate a material financial impact. ALS continues to monitor and address the incident to safeguard data and operational integrity.
Audit and Governance
Ernst & Young audited ALS’ FY26 financial statements, expressing an unqualified opinion. The audit highlighted key matters including the complexity of consolidating diverse international operations and revenue recognition across multiple business streams. ALS maintained strong governance and risk management practices throughout the year, with ongoing oversight of financial, operational, and climate-related risks.
Executive remuneration outcomes reflected the company’s strong financial performance, with the CEO and CFO achieving 95% and 97% of their short-term incentive maximums respectively. The FY23 long-term incentive awards vested at 72.1%, driven by strong EBITDA margin and total shareholder return performance.
What to Watch Next
Investors will be watching ALS’ half-year results due in November 2026 for indications of sustained momentum, particularly in the Minerals and Life Sciences segments. The commissioning of new hub laboratories and the impact of ongoing automation investments will be key operational milestones. Market participants will also track the company’s revised climate targets and transition plan expected in FY27, alongside management’s progress in addressing the cyber incident’s residual effects.
ALS’ ability to successfully integrate recent acquisitions, especially the York business, remains a focus, as does the appointment of new leadership in Minerals. The company’s strong balance sheet and flexible capital structure position it well to capitalise on growth opportunities amid evolving commodity markets and regulatory environments.
Bottom Line?
ALS has set a high bar with record profits and dividends, but integration challenges and a recent cyber incident underscore the need for operational vigilance as it targets future growth.
Questions in the middle?
- How will ALS’ revised 2030 climate targets shape its capital allocation and operational priorities?
- What progress can be expected on the turnaround of the York acquisition and its impact on Life Sciences margins?
- To what extent will automation and AI investments translate into sustainable margin expansion amid volatile commodity markets?